Dynamic contrast-enhanced MRI for monitoring bisphosphonate therapy in Paget’s disease of bone

The purpose of this study was to evaluate changes in regional bone perfusion in Paget’s disease (PD) following bisphosphonate therapy. We used dynamic contrast-enhanced MRI (DCE-MRI) for assessment of bone perfusion and compared MRI findings with alkaline phosphatase (AP) as a serum marker of bone t...

Full description

Saved in:
Bibliographic Details
Main Authors: Libicher, Martin (Author) , Kasperk, Christian (Author) , Daniels-Wredenhagen, Mark (Author) , Heye, Tobias (Author) , Kauczor, Hans-Ulrich (Author) , Nawroth, Peter Paul (Author) , Delorme, Stefan (Author) , Hosch, Waldemar P. (Author)
Format: Article (Journal)
Language:English
Published: 2013
In: Skeletal radiology
Year: 2013, Volume: 42, Issue: 2, Pages: 225-230
ISSN:1432-2161
DOI:10.1007/s00256-012-1423-4
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00256-012-1423-4
Get full text
Author Notes:Martin Libicher, C. Kasperk, M. Daniels-Wredenhagen, T. Heye, H.U. Kauczor, P. Nawroth, S. Delorme, W. Hosch
Description
Summary:The purpose of this study was to evaluate changes in regional bone perfusion in Paget’s disease (PD) following bisphosphonate therapy. We used dynamic contrast-enhanced MRI (DCE-MRI) for assessment of bone perfusion and compared MRI findings with alkaline phosphatase (AP) as a serum marker of bone turnover.
Item Description:Published online: 16 May 2012
Gesehen am 01.03.2022
Physical Description:Online Resource
ISSN:1432-2161
DOI:10.1007/s00256-012-1423-4